4'-Epi-doxorubicin, a new analogue of doxorubicin: A preliminary overview of preclinical and clinical data
Ganzina, F. (1983). 4'-Epi-doxorubicin, a new analogue of doxorubicin: A preliminary overview of preclinical and clinical data. Cancer Treat. Rev. 10, 1-22.
Evaluation of tetetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity
Heo D.S., Park J.-G., Hata K., Day R., Herberman R.B. and Whiteside T.L. (1990). Evaluation of tetetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. Cancer Res. 50, 3681-3690.
Tissue distribution and disposition of daunomycin (NSC-82151) in mice: Fluorometric and isotopic methods
Bachur N.R., Moor A.L., Bernstein J.G. and Liu A. (1970). Tissue distribution and disposition of daunomycin (NSC-82151) in mice: Fluorometric and isotopic methods. Cancer Chemother. Rep. 54, 89-98 .
Inhibition of doxorubicin-induced cell death in vitro and in vivo by cycloheximide
Furusawa S., Nakano S., Kosaka K., Takayanagi M., Takayanagi Y. and Sasaki K. (1995). Inhibition of doxorubicin-induced cell death in vitro and in vivo by cycloheximide. Biol. Pharm. Bull. 18, 1367-1372.
Rapid incorporation of label from ribonucleoside disphosphates into DNA by a cell-free high molecular weight fraction from animal cell nuclei
Noguchi H., Reddy G.P.V. and Pardee A.B. (1983). Rapid incorporation of label from ribonucleoside disphosphates into DNA by a cell-free high molecular weight fraction from animal cell nuclei. Cell. 32, 443-451.
Synthesis of labile, serum-dependent protein in early G1 controls animal cell growth
Rossow P.W., Riddle V.G. and Pardee A.B. (1979). Synthesis of labile, serum-dependent protein in early G1 controls animal cell growth. Proc. Natl. Acad. Sci. USA. 76, 4446-4450.
Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines a model of doxorubicin-sensitive and -resistant rat glioblastoma cells
Schot B. and Robert J. (1989). Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines a model of doxorubicin-sensitive and -resistant rat glioblastoma cells. Biochem. Pharmacol. 38, 167-172.